GENeuver Biologics

The submission describes an ML-based tool for CRISPR gene editing, which has high theoretical utility. However, the claims are highly suspicious and unverifiable. An audience reach of 'everyone' and traction evidence stating 'most people have used my product' are entirely unrealistic for a specialized bioinformatics platform. The mention of 'all time marketcap: 500000' in the monthly revenue field implies a speculative asset or crypto token rather than verifiable business revenue. The submission lacks critical details, contains significant red flags, and provides vague responses, resulting in a low score commensurate with minimal verifiable traction.